Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12621000380897
Ethics application status
Approved
Date submitted
3/02/2021
Date registered
6/04/2021
Date last updated
10/05/2024
Date data sharing statement initially provided
6/04/2021
Type of registration
Retrospectively registered

Titles & IDs
Public title
Transdisciplinary stroke assessment: Can it improve allied health efficiency and care on an acute stroke unit?
Scientific title
Transdisciplinary stroke assessment: Can it improve allied health efficiency and care for patients admitting with TIA or stroke on an acute stroke unit?
Secondary ID [1] 303322 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Transdisciplinary Initial Neurological Screening Assessment (TINSA) Project
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Stroke 320557 0
Transient Ischaemic Attack (TIA) 320558 0
Condition category
Condition code
Public Health 318412 318412 0 0
Health service research
Stroke 318797 318797 0 0
Haemorrhagic
Stroke 318798 318798 0 0
Ischaemic

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Transdisciplinary Initial Neurological Screening Assessment (TINSA).

The TINSA is a new assessment which combines assessments and tasks of routine physiotherapy, occupational therapy, social work, and speech pathology assessments. It will replace discipline-specific assessments, and acts as a trigger for referrals to allied health professionals.

The TINSA has been developed and tested via task analysis, discussion with discipline experts, 2 simulation process tests, and pilot testing. The TINSA will be administered by a registered occupational therapist or physiotherapist, who have completed the TINSA training package (involving a manual, 9 eLearning modules and a practical assessment). The TINSA training package has been specifically designed for this study and is estimated to take a total of 4 hours to complete. The occupational therapist or physiotherapist will administer the TINSA face to face on day 1 of admission to the Acute Stroke Unit (i.e., within 24-48 hours of admission to the Acute Stroke Unit).

During the study periods where the TINSA is administered (Phase 2 with mild stroke/TIA presentations and Phase 4 with moderate/severe stroke presentations), the time taken to administer will be recorded. The TINS was timed during simulations, and on the second simulation was recorded to take 35-50 minutes to complete. For patients receiving the TINSA, this means they will receive a one-on-one assessment administered by either an occupational therapist or a physiotherapist. Patients will only receive the TINSA once/admission. The TINSA involves verbal questions, a brief communication screen and a physical assessment (including a mobility assessment). After the assessment, the occupational therapist or the physiotherapist will make referrals to the wider allied health team, as per their clinical training and judgement. After the novel TINSA has been administered and subsequent AH referrals made, AH input (i.e. the treatment, re-assessment, discharge panning, follow-up) will continue as per usual care. If no further allied health is indicated after the TINSA, the assessor can discharge the patient (i.e. safe to return home). Participants will be involved in the study for a total of 3 months (i.e., from admission to hospital to the follow-up phone call at 3 months after admission to hospital).

During the study, adherence to the intervention will be monitored by the primary investigator when the study data is entered into the study database. Gaps in the data will be identified as flagged to the allied health team. Also, the primary investigator will check-in with the allied health team on a fortnightly basis during the regular study meeting. This meeting will be used as a space to de-brief, problem-solve and encourage ongoing adherence to the intervention / study protocol.
Intervention code [1] 319630 0
Treatment: Other
Comparator / control treatment
Usual care (multidisciplinary assessments).

During the baseline study periods (Phase 1 - prior to implementation of the novel TINS with people experiencing mild stroke/TIA; and Phase 3 - prior to implementation of the novel TINS with people experiencing moderate/severe stroke), multidisciplinary assessment will be administered and evaluated. The participants will receive separate and discipline-specific assessment by the speech pathologist, social worker, occupational therapist and physiotherapist as per usual practice. Administration of all allied health assessments will be timed. On average may take on average 45-60 minutes/assessment, that is 60 minutes for speech pathology, 60 minutes for occupational therapy and 45-50 minutes for physiotherapy (up to a total of 2 hours 50 minutes over three separate occasions). Participants will be involved in the study for a total of 3 months (i.e., from admission to hospital to the follow-up phone call at 3 months after admission to hospital).
Control group
Active

Outcomes
Primary outcome [1] 326394 0
Total time spent completing allied health assessment (in minutes). This includes time taken to read the Current Attendance Record (CAR), plus time taken to administer the initial assessment, plus time taken to record results after assessment administration.

Total time will be recorded by the occupational therapist, physiotherapist, and speech pathologist by recording the time on their smart phones (e.g. 14:13) when they 1) pick up the patient chart to read the notes (time in) and 2) put the down the patient chart (time out). Plus 3) time the assessment is commenced (time in) and 4) time the assessment is completed (time out). Plus 5) time the clinician commences writing the note in the patient chart (time in) and 6) time the clinician finishes writing the note in the patient chart (time out).
Timepoint [1] 326394 0
The initial occasion of service (i.e., day 1 of admission to the Acute Stroke Unit).
Secondary outcome [1] 391294 0
Length of stay in days. This outcome will be assessed via a retrospective audit of the patient's medical record (from day admitted to day discharged).
Timepoint [1] 391294 0
Data collected after the patient discharges from hospital (note days/weeks from admission to discharge vary widely for each patient).
Secondary outcome [2] 391295 0
Time (days and hours) from admission to commencement of allied health intervention (including occupational therapy, physiotherapy, speech pathology). This outcome will be assessed via a retrospective audit of the patient's medical record.
Timepoint [2] 391295 0
Data collected after the patient discharges from hospital (note days/weeks from admission to discharge vary widely for each patient).
Secondary outcome [3] 391296 0
Time (days and hours) from admission to discharge from allied health (including occupational therapy, physiotherapy, speech pathology). This outcome will be assessed via a retrospective audit of the patient's medical record.
Timepoint [3] 391296 0
Data collected after the patient discharges from hospital (note days/weeks from admission to discharge vary widely for each patient). This outcome will be assessed via a retrospective audit of the patient's medical record.
Secondary outcome [4] 391297 0
Occasions of face-to-face service with allied health (total occasions of occupational therapy, physiotherapy, speech pathology and social work). This outcome will be assessed via a retrospective audit of the patient's medical record.
Timepoint [4] 391297 0
Data collected after the patient discharges from hospital (note days/weeks from admission to discharge vary widely for each patient).
Secondary outcome [5] 391298 0
Time (in days and hours) from admission to when the ward social work referral was enacted. This outcome will be assessed via a retrospective audit of the patient's medical record.
Timepoint [5] 391298 0
Data collected after the patient discharges from hospital (note days/weeks from admission to discharge vary widely for each patient).
Secondary outcome [6] 391299 0
Number of inappropriate referrals to allied health professionals (i.e., referrals to occupational therapy, physiotherapy, speech pathology or social work where no treatment is indicated after the initial assessment). This outcome will be assessed via a retrospective audit of the patient's medical record.
Timepoint [6] 391299 0
Data collected after the patient discharges from hospital (note days/weeks from admission to discharge vary widely for each patient).
Secondary outcome [7] 391300 0
Number of patients referred for allied health assessment who had a negative stroke diagnosis on MRI. This outcome will be assessed via a retrospective audit of the patient's medical record.
Timepoint [7] 391300 0
Data collected after the patient discharges from hospital (note days/weeks from admission to discharge vary widely for each patient).
Secondary outcome [8] 391301 0
Compliance to the acute stroke clinical care standards. This outcome will be assessed via a retrospective audit of the patient's medical record, where we will assess if the patient seen within 24-48 hours of admission by a physiotherapist (yes/no), within 48 hours by an occupational therapist (yes/no), and within 48 hours by a speech pathologist (yes/no). All items listed will be assessed as a composite secondary outcome.
Timepoint [8] 391301 0
Data collected after the patient discharges from hospital (note the days/weeks from admission to discharge vary widely for each patient).
Secondary outcome [9] 391302 0
Total number of patient falls during the hospital admission. This outcome will be assessed via a retrospective audit of the patient's medical record.
Timepoint [9] 391302 0
Data collected fortnightly throughout study periods. This outcome will be assessed via a retrospective audit of the patient's medical record.
Secondary outcome [10] 391303 0
Missed referrals other than those due to a change in condition (defined by when allied health professionals do not receive a referral from other allied health professionals who have completed the initial stroke assessment/s). This outcome will be assessed via a retrospective audit of the patient's medical record.
Timepoint [10] 391303 0
Data collected after the patient discharges from hospital (note days/weeks from admission to discharge vary widely for each patient).
Secondary outcome [11] 391304 0
Failed discharge (defined as unplanned readmission within 30 days not related to a new episode of care). This outcome will be assessed via a retrospective audit of the patient's medical record.
Timepoint [11] 391304 0
Data collected after 30 days post patient discharge from hospital.
Secondary outcome [12] 391305 0
Long-term health outcomes (measure of disability/dependence in activities of daily living) using the Modified Rankin Scale. This will be assessed via a phone interview. The Modified Rankin Scale is from a validated source, originally developed by Rankin J (1957).
Timepoint [12] 391305 0
3 months after admission to the Acute Stroke Unit via phone call interview.
Secondary outcome [13] 391306 0
Organisational cost savings. This outcome will be assessed using 3 scopes, where all items will be assessed as a composite secondary outcome.
1) For analysis of scope 1, we will use the variable cost of allied health staff time completing initial assessment (minutes). This data will be collected using times recorded by staff (occupational therapy, physiotherapy and speech pathology) and costings from the Mater Health Practitioners’ Enterprise Agreement.
2) For analysis of scope 2, we will use costs pertaining to space (i.e. days the hospital bed space is used until discharge from hospital). We will also use variable costs of health events during admission (i.e. number of Medical Emergency Team (MET) calls) and medical procedures/tests (i.e. number of MRI and CT scans). The costs pertaining to consumables will include personal protective equipment used (number of items), hospital gown and linen use (number of items) and food (number of meals). This data will be collected using hospital records and overhead daily costs appropriate to the Mater setting. These costs will also be used in the analysis of scope 2.
3) We will consider further economic evaluation when we know the outcomes of the 3-month follow-up (scope 3). At 3-months after admission to the ASU, patients will be asked questions related to health events since discharge in regards to falls in the community, readmission to hospital following a failed discharge, greater reliance on formal/informal care (see questions listed above in previous outcome measure).
Timepoint [13] 391306 0
This analysis will occur at 3 months after a patient has admitted to the hospital.
Secondary outcome [14] 391307 0
Patient satisfaction. This outcome will be assessment via a written, study-specific patient satisfaction survey.
Timepoint [14] 391307 0
Patient satisfaction. This outcome will be assessment via a written, study-specific patient satisfaction survey on day 2 of admission to the Acute Stroke Unit.

These secondary outcome is unchanged, but will only be used during Phase 1 and 2 (i.e., not Phase 3 and 4 which represent the expanded phases of the study).
Secondary outcome [15] 391308 0
Staff satisfaction. This outcome will be assessment via a written, study-specific staff satisfaction survey.
Timepoint [15] 391308 0
During the last week of the transdisciplinary study phase.
Secondary outcome [16] 391309 0
Staff interprofessional trust. This outcome will be assessment via a written staff trust survey during the first week of Phase 1, last week of Phase 3, last week of Phase 4, and a voluntary staff focus group (at the end of Phase 4). The interprofessional trust survey is a combination of a "fit-for-purpose" survey of questions designed specifically for the study (based on the literature pertaining to determinants of trust). A validated survey is also used: Multifaceted Measure of Team Trust, Costa & Anderson, 2010.
Timepoint [16] 391309 0
The written survey will be completed during the first week of the usual care study phase 1; during the last week of usual care study phase 3; and during the last week of the transdisciplinary study phase 4. The focus group will be completed after the Phase 4 of the study has been completed.
Secondary outcome [17] 392541 0
Health outcomes (measure of quality of life) using the EQ-5D-3L. This outcome will be assessed via a phone interview. The EQ-5D-3L is from a validated source: Euroqol https://euroqol.org/eq-5d-instruments/eq-5d-3l-about/
Timepoint [17] 392541 0
3 months after admission to the Acute Stroke Unit.
Secondary outcome [18] 408183 0
Time from admission to communication assessment is completed. This outcome will be assessed via a retrospective audit of the patient's medical record.
Timepoint [18] 408183 0
Data collected after the patient discharges from hospital (note the days/weeks from admission to discharge vary widely for each patient).
Secondary outcome [19] 408184 0
Time from admission to mobility assessment is completed. This outcome will be assessed via a retrospective audit of the patient's medical record.
Timepoint [19] 408184 0
Data collected after the patient discharges from hospital (note the days/weeks from admission to discharge vary widely for each patient).
Secondary outcome [20] 408185 0
Audit of completed TINSA forms to determine the utility of the form including the number of sections completed, number of allied health referrals made, and number of "stop and refer prompts" used.
Timepoint [20] 408185 0
Data collected after the patient discharges from hospital (note the days/weeks from admission to discharge vary widely for each patient).
Secondary outcome [21] 408186 0
Number of adverse events that may be related to allied health input (i.e., extension of stroke, aspiration pneumonia, pressure injury). For example, an extension of stroke would be confirmed and documents in the medical record after a repeat MRI scan. Aspiration pneumonia would b diagnoses by the medical professionals and documented as a diagnosis in the medical record. Pressure injuries that develop in hospital will be entered into the incident reporting system, documented in the medical record, and monitored using the relevant nursing care plan. Therefore all adverse outcomes described will be assessed via a retrospective audit of the patient's medical record and by reviewing the hospital's incident reporting system (ERIC).
Timepoint [21] 408186 0
Data collected after the patient discharges from hospital (note the days/weeks from admission to discharge vary widely for each patient).

Eligibility
Key inclusion criteria
PHASES 1 & 2:
Patient eligibility will be determined via the following inclusion criteria:
• Consenting patients admitted to the Mater Hospital Brisbane Acute Stroke Unit (Neurosciences Ward) Level 8, Salmon Building during the study periods
• Consenting patients placed on the Mater stroke pathway (i.e., those who have ‘blanket’ allied health referral as per usual care) who present with: Transient Ischaemic Attack (TIA); Possible stroke and who have not received a diagnosis via the MRI report within 24-48 hours of admission; Minor neurological signs/symptoms as determined by a review of the chart notes by the ward occupational therapist or physiotherapist (i.e., patients limb strength above grade 3/5 classification, and/or without visuospatial or sensorimotor neglect, and/or without severe aphasia, and/or who are able to follow 1 stage commands).

Additional patient inclusion criterion for evaluation of novel TINSA:
• Patients who have provided consent and have a Montreal Cognitive Assessment (MoCA) score of greater than or equal to 19/30 (i.e. intact cognition and recall processes) will be asked to complete the patient satisfaction survey and follow up phone call.

PHASES 3 & 4:
Patient eligibility will be determined via the following inclusion criteria:
• Consenting patients admitted to the Mater Hospital Brisbane Acute Stroke Unit (Neurosciences Ward) Level 8, Salmon Building during the study periods
• Consenting patients placed on the Mater stroke pathway (i.e., those who have ‘blanket’ allied health referral as per usual care) who present with possible (i.e., have not received a diagnosis via the MRI report within 24-48 hours of admission) or confirmed stroke with moderate to severe neurological signs/symptoms as determined by a review of the chart notes by the ward occupational therapist or physiotherapist. I.e., patients with limb strength below grade 3/5 classification, and/or with visuospatial or sensorimotor neglect, and/or with severe aphasia, and/or who are not able to follow 1 stage commands.

STAFF INCLUSION CRITERIA:
• All consenting Mater staff (nursing, medical and allied health) and Active Rehabilitation staff working in and caring for patients with stroke in the ASU under the transdisciplinary model of assessment.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Patient exclusion criteria (all phases):
• Patients who are admitted to the Acute Stroke Unit over a weekend (Saturday and Sunday) or on a public holiday.
• Patients with stroke who are not transferred to the Acute Stroke Unit.
• Patients with stroke who received allied health initial assessment before transfer to the Acute Stroke Unit and/or placed on the stroke pathway.
• Patients who do not speak English where a third-party professional interpreter is unavailable to assist with translation.
• Patients who have already been included in the study at an earlier time point (i.e., have been readmitted).

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Not applicable.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other
Other design features
In Phase 1 and 3 the study, participants will receive usual multidisciplinary assessment via allied health discipline-specific assessments. For Phases 2 and 4 of the study, participants will receive novel transdisciplinary assessment via the TINSA.
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
Sample size:
According to the InformMe statistics, the Mater’s ASU has between 200-349 admissions per year (National Stroke Foundation, 2019). This total includes patients admitting with TIA, possible strokes, mild stroke, and moderate – severe strokes. The expected number of patients admitted who will meet the eligibility criteria is approximately between 100-175 patients per year, or 50-88 patients per any 6-month phase (i.e. the duration of each of Phase 1 and 2). We are assuming the nature of patients in both phases will be similar in terms of demographics and clinical characteristics. Phases 3 and 4 will recruit 26 participants, which is therefore estimated to take approximately 3 months per Phase.

The sample size of patients who provide qualitative feedback via the survey is likely to be smaller than the estimated 50-88 patients per 6-months (or 26 participants per approximately 3-months), as patients require a MoCA score of greater than or equal to 19/30 to be eligible to complete the survey. The sample size of staff who complete the satisfaction and trust surveys will also be limited to the number of staff working on Mater’s ASU (approximately 20 nursing staff, 12 allied health staff and 6 doctors).

The following power calculation demonstrates the required participant number per group to give sufficient power to find a minimally important difference in primary aim 1. The variation in time taken to complete the initial stroke assessment may range from the shortest assessment at 30 minutes for speech pathology, 20 minutes for occupational therapy and 30 minutes for physiotherapy (80 minutes total) to the longest assessment at 90 minutes for speech pathology, 60 minutes for occupational therapy and 60 minutes for physiotherapy (210 minutes total). The smallest clinically important improvement would be a decrease of 20 minutes in average total assessment time. Assuming a similar distribution of patients in each assessment group, a significance level of 0.05, 80% power and a standard deviation of 25 minutes, 26 patients per group will be required to detect a 20 minute difference (considered to be the minimal important difference) in total assessment time. Therefore, we will have sufficient power to detect a difference when data collection is run over a 6-month period per Phase 1 and Phase 2, as we expect 50-88 patients per each 6-month phase. We will also have sufficient power to detect a difference when data collection is run over a 3-month period per Phase 3 and Phase 4, as we expect to recruit 26 participants (which is required for sufficiently power to detect a difference).

Statistical analysis:
Patient characteristics, outcomes and quantitative survey responses will be summarised for each assessment group (Phase 1 multidisciplinary and Phase 2 transdisciplinary) using frequency and percent for categorical variables, means and standard deviations for approximately normally distributed continuous variables and medians and interquartile ranges for non-normally distributed continuous variables. Selected outcomes will additionally be summarised by month. Differences between assessment groups will be estimated using the general linear model for continuous outcomes and logistic regression for categorical outcomes. Balance of potential confounders between the assessment groups will be investigated and multivariable adjustment will be employed where there is an apparent confounding effect. Results will be presented as differences (continuous outcomes) and odds ratios (categorical outcomes) with 95% confidence intervals. Cohen’s D will not be used as the primary outcome is time and the magnitude of the effect will be very clear. All analyses will be performed using Stata 15.1 (Stata Corp, College Station, TX) and a p-value <0.05 will be considered statistically significant throughout all inferential analysis.


To analyse the economic implications, the mean cost per patient will be calculated using a decision tree analysis with expected values calculated from all possible patient scenarios. This will compare possible costs incurred during Phase 1 (usual multidisciplinary assessment) and during Phase 2 (novel transdisciplinary assessment). The main cost considered will be assessment time. After the initial assessment patients will either need “no further allied health occasions of service” (i.e. the patient receives no further allied health assessment or treatment before discharge from hospital) or “ongoing allied health occasions of service” (i.e. further allied health assessment or treatment is required before discharge). Measures such as allied health occasions of service will be considered. of At 3-months after admission to the Acute Stroke Unit, we will use a quality of life measure (EQ-3L-5D), a disability measure (Modified Rankin Scale), and answer questions related to health events since discharge to explore potential consequences (i.e. health and cost outcomes). Every resource that falls in scope 1 (assessment time), scope 2 (hospital stay) or scope 3 (long term impacts at 3 months) that is found to have a clinically significantly difference between the novel TINSA and the existing multidisciplinary assessment will be costed and included in an incremental analysis. A one-way deterministic sensitivity analysis will be completed to understand uncertainty in cost estimates across reasonable scenarios.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
22/02/2021
Date of last participant enrolment
Anticipated
30/04/2023
Actual
31/12/2022
Date of last data collection
Anticipated
30/07/2023
Actual
5/04/2023
Sample size
Target
200
Accrual to date
Final
186
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 18565 0
Mater Adult Hospital - South Brisbane
Recruitment postcode(s) [1] 32926 0
4101 - South Brisbane

Funding & Sponsors
Funding source category [1] 307738 0
Government body
Name [1] 307738 0
National Health and Medical Research Council
Country [1] 307738 0
Australia
Funding source category [2] 307742 0
Government body
Name [2] 307742 0
Allied Health Professions' Office of Queensland
Country [2] 307742 0
Australia
Funding source category [3] 307743 0
Hospital
Name [3] 307743 0
Mater Foundation
Country [3] 307743 0
Australia
Funding source category [4] 307744 0
University
Name [4] 307744 0
University of Queensland
Country [4] 307744 0
Australia
Primary sponsor type
Hospital
Name
Mater Research Institute
Address
Mater Research, Level 3 Aubigny Place, Raymond Terrace, South Brisbane QLD 4101
Country
Australia
Secondary sponsor category [1] 308440 0
University
Name [1] 308440 0
The University of Queensland
Address [1] 308440 0
The University of Queensland, St Lucia, QLD 4072
Country [1] 308440 0
Australia
Other collaborator category [1] 281629 0
Individual
Name [1] 281629 0
Professor Theresa Green
Address [1] 281629 0
School of Nursing, Midwifery and Social Work, The University of Queensland, St Lucia, QLD 4072
Country [1] 281629 0
Australia
Other collaborator category [2] 281630 0
Individual
Name [2] 281630 0
Professor Alexandra McCarthy
Address [2] 281630 0
School of Nursing, Midwifery and Social Work, The University of Queensland, St Lucia, QLD 4072
Country [2] 281630 0
Australia
Other collaborator category [3] 281631 0
Individual
Name [3] 281631 0
Dr Marcin Sowa
Address [3] 281631 0
Faculty of Business, Economics and Law, The University of Queensland, St Lucia, QLD 4072
Country [3] 281631 0
Australia
Other collaborator category [4] 281632 0
Individual
Name [4] 281632 0
Dr Liisa Laakso
Address [4] 281632 0
Mater Research, Level 2 Aubigny Place, Raymond Terrace, South Brisbane QLD 4101
Country [4] 281632 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 307765 0
Mater Misericordiae Ltd HREC Office
Ethics committee address [1] 307765 0
Ethics committee country [1] 307765 0
Australia
Date submitted for ethics approval [1] 307765 0
09/09/2020
Approval date [1] 307765 0
04/11/2020
Ethics approval number [1] 307765 0
66933

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 108414 0
Miss Aleysha Martin
Address 108414 0
Mater Research, Level 2 Aubigny Place, Raymond Terrace, South Brisbane, QLD, 4101
Country 108414 0
Australia
Phone 108414 0
+61 457993248
Fax 108414 0
Email 108414 0
aleysha.martin@uqconnect.edu.au
Contact person for public queries
Name 108415 0
Aleysha Martin
Address 108415 0
Mater Research, Level 2 Aubigny Place, Raymond Terrace, South Brisbane, QLD, 4101
Country 108415 0
Australia
Phone 108415 0
+61 457993248
Fax 108415 0
Email 108415 0
aleysha.martin@uqconnect.edu.au
Contact person for scientific queries
Name 108416 0
Aleysha Martin
Address 108416 0
Mater Research, Level 2 Aubigny Place, Raymond Terrace, South Brisbane, QLD, 4101
Country 108416 0
Australia
Phone 108416 0
+61 457993248
Fax 108416 0
Email 108416 0
aleysha.martin@uqconnect.edu.au

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
What data in particular will be shared?
Unidentifiable individual participant data underlying published results.
When will data be available (start and end dates)?
Available presently, no end date.
Available to whom?
Available via UQ eSpace on a case-by-case basis at the discretion of the Principal Investigator and on reasonable request. E.g., sharing of data would be considered for clinician researchers/researchers who provide a relevant and methodologically sound proposal.
Available for what types of analyses?
The raw data will be made available on reasonable request for relevant and methodologically sound proposals, and for the purpose to achieve the aim/s in the proposal.
How or where can data be obtained?
Unidentifiable individual participant raw data is available: https://doi.org/10.48610/6fab0d9
after an approval ethics amendment. This has been updated following an update in step 12.


What supporting documents are/will be available?

Doc. No.TypeCitationLinkEmailOther DetailsAttachment
10428Ethical approval    381339-(Uploaded-03-02-2021-11-31-47)-Study-related document.pdf



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseTransdisciplinary allied health assessment for patients with stroke: a pre-/post- mixed methods study protocol.2022https://dx.doi.org/10.1186/s12913-022-08926-y
N.B. These documents automatically identified may not have been verified by the study sponsor.